CDH11 expression in malignancies e.g. breast cancer is associated with poor outcome and has been also reported to promote a pro-invasive behavior in synovial fibroblasts40–42, rendering CDH11 an attractive target for therapeutic intervention43. The gene discussed is CDH11; the disease is breast cancer.